Robinson SL, Thiele TE (2017). "The Role of Neuropeptide y (NPY) in Alcohol and Drug Abuse Disorders". The Role of Neuropeptides in Addiction and Disorders of Excessive Consumption. International Review of Neurobiology. Vol. 136. pp. 177–197. doi:10.1016/bs.irn.2017.06.005. ISBN9780128124734. PMID29056151.
Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, et al. (July 2007). "Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome". Nature Medicine. 13 (7): 803–811. doi:10.1038/nm1611. PMID17603492. S2CID25675166.
Kask A, Harro J, von Hörsten S, Redrobe JP, Dumont Y, Quirion R (May 2002). "The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y". Neuroscience and Biobehavioral Reviews. 26 (3): 259–283. doi:10.1016/s0149-7634(01)00066-5. PMID12034130. S2CID34688422.
Dhamad A, Zampiga M, Greene ES, Sirri F, Dridi S (September 2021). "Neuropeptide Y and its receptors are expressed in chicken skeletal muscle and regulate mitochondrial function". General and Comparative Endocrinology. 310: 113798. doi:10.1016/j.ygcen.2021.113798. PMID33961876.
Decressac M, Wright B, David B, Tyers P, Jaber M, Barker RA, Gaillard A (March 2011). "Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis". Hippocampus. 21 (3): 233–238. doi:10.1002/hipo.20765. PMID20095007. S2CID4014094.
Howell OW, Doyle K, Goodman JH, Scharfman HE, Herzog H, Pringle A, et al. (May 2005). "Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus". Journal of Neurochemistry. 93 (3): 560–570. doi:10.1111/j.1471-4159.2005.03057.x. PMID15836615. S2CID1531546.
Malva JO, Xapelli S, Baptista S, Valero J, Agasse F, Ferreira R, Silva AP (December 2012). "Multifaces of neuropeptide Y in the brain--neuroprotection, neurogenesis and neuroinflammation". Neuropeptides. 46 (6): 299–308. doi:10.1016/j.npep.2012.09.001. PMID23116540. S2CID9366746.
Morris BJ (December 1989). "Neuronal localisation of neuropeptide Y gene expression in rat brain". The Journal of Comparative Neurology. 290 (3): 358–368. doi:10.1002/cne.902900305. PMID2592617. S2CID36876107.
Haas DA, George SR (October 1989). "Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission". Brain Research. 498 (2): 333–338. doi:10.1016/0006-8993(89)91112-8. PMID2551461. S2CID36802464.
Edwardson JA, Hough CA (April 1975). "The pituitary-adrenal system of the genetically obese (ob/ob) mouse". The Journal of Endocrinology. 65 (1): 99–107. doi:10.1677/joe.0.0650099. PMID167093.
Hanson ES, Dallman MF (April 1995). "Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis". Journal of Neuroendocrinology. 7 (4): 273–279. doi:10.1111/j.1365-2826.1995.tb00757.x. PMID7647769. S2CID25471741.
White BD, Dean RG, Edwards GL, Martin RJ (May 1994). "Type II corticosteroid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats". The American Journal of Physiology. 266 (5 Pt 2): R1523–R1529. doi:10.1152/ajpregu.1994.266.5.R1523. PMID8203629.
King PJ, Widdowson PS, Doods HN, Williams G (August 1999). "Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices". Journal of Neurochemistry. 73 (2): 641–646. doi:10.1046/j.1471-4159.1999.0730641.x. PMID10428060. S2CID8022493.
King PJ, Williams G, Doods H, Widdowson PS (May 2000). "Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release". European Journal of Pharmacology. 396 (1): R1–R3. doi:10.1016/S0014-2999(00)00230-2. PMID10822055.
Yukimura Y, Bray GA (1978). "Effects of adrenalectomy on body weight and the size and number of fat cells in the Zucker (fatty) rat". Endocrine Research Communications. 5 (3): 189–198. doi:10.1080/07435807809083752. PMID747998.
Powley TL, Morton SA (April 1976). "Hypophysectomy and regulation of body weight in the genetically obese Zucker rat". The American Journal of Physiology. 230 (4): 982–987. doi:10.1152/ajplegacy.1976.230.4.982. PMID1267030.
Robinson SL, Thiele TE (2017). "The Role of Neuropeptide y (NPY) in Alcohol and Drug Abuse Disorders". The Role of Neuropeptides in Addiction and Disorders of Excessive Consumption. International Review of Neurobiology. Vol. 136. pp. 177–197. doi:10.1016/bs.irn.2017.06.005. ISBN9780128124734. PMID29056151.
Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, et al. (July 2007). "Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome". Nature Medicine. 13 (7): 803–811. doi:10.1038/nm1611. PMID17603492. S2CID25675166.
Kask A, Harro J, von Hörsten S, Redrobe JP, Dumont Y, Quirion R (May 2002). "The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y". Neuroscience and Biobehavioral Reviews. 26 (3): 259–283. doi:10.1016/s0149-7634(01)00066-5. PMID12034130. S2CID34688422.
Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, et al. (March 1998). "XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors". Pharmacological Reviews. 50 (1): 143–150. PMID9549761.
Dhamad A, Zampiga M, Greene ES, Sirri F, Dridi S (September 2021). "Neuropeptide Y and its receptors are expressed in chicken skeletal muscle and regulate mitochondrial function". General and Comparative Endocrinology. 310: 113798. doi:10.1016/j.ygcen.2021.113798. PMID33961876.
Decressac M, Wright B, David B, Tyers P, Jaber M, Barker RA, Gaillard A (March 2011). "Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis". Hippocampus. 21 (3): 233–238. doi:10.1002/hipo.20765. PMID20095007. S2CID4014094.
Howell OW, Doyle K, Goodman JH, Scharfman HE, Herzog H, Pringle A, et al. (May 2005). "Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus". Journal of Neurochemistry. 93 (3): 560–570. doi:10.1111/j.1471-4159.2005.03057.x. PMID15836615. S2CID1531546.
Malva JO, Xapelli S, Baptista S, Valero J, Agasse F, Ferreira R, Silva AP (December 2012). "Multifaces of neuropeptide Y in the brain--neuroprotection, neurogenesis and neuroinflammation". Neuropeptides. 46 (6): 299–308. doi:10.1016/j.npep.2012.09.001. PMID23116540. S2CID9366746.
Morris BJ (December 1989). "Neuronal localisation of neuropeptide Y gene expression in rat brain". The Journal of Comparative Neurology. 290 (3): 358–368. doi:10.1002/cne.902900305. PMID2592617. S2CID36876107.
Haas DA, George SR (October 1989). "Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission". Brain Research. 498 (2): 333–338. doi:10.1016/0006-8993(89)91112-8. PMID2551461. S2CID36802464.
Edwardson JA, Hough CA (April 1975). "The pituitary-adrenal system of the genetically obese (ob/ob) mouse". The Journal of Endocrinology. 65 (1): 99–107. doi:10.1677/joe.0.0650099. PMID167093.
Hanson ES, Dallman MF (April 1995). "Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis". Journal of Neuroendocrinology. 7 (4): 273–279. doi:10.1111/j.1365-2826.1995.tb00757.x. PMID7647769. S2CID25471741.
White BD, Dean RG, Edwards GL, Martin RJ (May 1994). "Type II corticosteroid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats". The American Journal of Physiology. 266 (5 Pt 2): R1523–R1529. doi:10.1152/ajpregu.1994.266.5.R1523. PMID8203629.
King PJ, Widdowson PS, Doods HN, Williams G (August 1999). "Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices". Journal of Neurochemistry. 73 (2): 641–646. doi:10.1046/j.1471-4159.1999.0730641.x. PMID10428060. S2CID8022493.
King PJ, Williams G, Doods H, Widdowson PS (May 2000). "Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release". European Journal of Pharmacology. 396 (1): R1–R3. doi:10.1016/S0014-2999(00)00230-2. PMID10822055.
Yukimura Y, Bray GA (1978). "Effects of adrenalectomy on body weight and the size and number of fat cells in the Zucker (fatty) rat". Endocrine Research Communications. 5 (3): 189–198. doi:10.1080/07435807809083752. PMID747998.
Powley TL, Morton SA (April 1976). "Hypophysectomy and regulation of body weight in the genetically obese Zucker rat". The American Journal of Physiology. 230 (4): 982–987. doi:10.1152/ajplegacy.1976.230.4.982. PMID1267030.
Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, et al. (July 2007). "Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome". Nature Medicine. 13 (7): 803–811. doi:10.1038/nm1611. PMID17603492. S2CID25675166.
Kask A, Harro J, von Hörsten S, Redrobe JP, Dumont Y, Quirion R (May 2002). "The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y". Neuroscience and Biobehavioral Reviews. 26 (3): 259–283. doi:10.1016/s0149-7634(01)00066-5. PMID12034130. S2CID34688422.
Decressac M, Wright B, David B, Tyers P, Jaber M, Barker RA, Gaillard A (March 2011). "Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis". Hippocampus. 21 (3): 233–238. doi:10.1002/hipo.20765. PMID20095007. S2CID4014094.
Howell OW, Doyle K, Goodman JH, Scharfman HE, Herzog H, Pringle A, et al. (May 2005). "Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus". Journal of Neurochemistry. 93 (3): 560–570. doi:10.1111/j.1471-4159.2005.03057.x. PMID15836615. S2CID1531546.
Malva JO, Xapelli S, Baptista S, Valero J, Agasse F, Ferreira R, Silva AP (December 2012). "Multifaces of neuropeptide Y in the brain--neuroprotection, neurogenesis and neuroinflammation". Neuropeptides. 46 (6): 299–308. doi:10.1016/j.npep.2012.09.001. PMID23116540. S2CID9366746.
Morris BJ (December 1989). "Neuronal localisation of neuropeptide Y gene expression in rat brain". The Journal of Comparative Neurology. 290 (3): 358–368. doi:10.1002/cne.902900305. PMID2592617. S2CID36876107.
Haas DA, George SR (October 1989). "Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission". Brain Research. 498 (2): 333–338. doi:10.1016/0006-8993(89)91112-8. PMID2551461. S2CID36802464.
Hanson ES, Dallman MF (April 1995). "Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis". Journal of Neuroendocrinology. 7 (4): 273–279. doi:10.1111/j.1365-2826.1995.tb00757.x. PMID7647769. S2CID25471741.
King PJ, Widdowson PS, Doods HN, Williams G (August 1999). "Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices". Journal of Neurochemistry. 73 (2): 641–646. doi:10.1046/j.1471-4159.1999.0730641.x. PMID10428060. S2CID8022493.
Dryden S, Pickavance L, Frankish HM, Williams G (September 1995). "Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats". Brain Research. 690 (2): 185–188. doi:10.1016/0006-8993(95)00628-4. PMID8535835. S2CID1857168.